Related Experiment Video
Updated: Feb 8, 2026

Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence
Published on: February 10, 2023
Single-Agent Gemcitabine in Heavily Pretreated Ovarian Cancer: Experience from a Canadian Tertiary Centre
Samantha Taylor1, Peter Scalia1, Raanan Meyer2
1Department of Gynecologic Oncology, Jewish General Hospital, McGill University, QC.
Objectives:
There is limited real word data regarding the utilization of gemcitabine as a single agent in ovarian cancer (OC). We aimed to study the outcomes of treating recurrent OC with single-agent gemcitabine.
Methods:
We conducted a retrospective study, including patients with recurrent OC who were treated with single-agent gemcitabine. Patients who received gemcitabine in combination with other agents were excluded. Our primary outcome was the overall survival (OS) of patients treated with single-agent gemcitabine.
Results:
Overall, 18 patients were included. The median age of patients was 59 years (IQR 49-63). Most patients (67%) had an Eastern Cooperative Oncology Group performance status of 1. The median number of lines of treatments prior to gemcitabine was 4 (IQR 3-5). The median duration on gemcitabine was 2 months (IQR 1-4), and the median OS was 4 months (95% CI 1-6). One patient had a reaction to treatment after the first infusion and treatment was discontinued. Four patients (22%) had at least 1 additional line of treatment following gemcitabine. During gemcitabine treatment, 67% of patients were admitted, and 61% of patients died within 30 days of treatment.
Conclusions:
Single-agent gemcitabine in heavily pretreated recurrent OC is associated with a median OS of 4 months, and some patients even benefit from further lines of treatment.
Related Concept Videos
Tertiary Healthcare System
Nomenclature of Secondary and Tertiary Amines
What is an Experiment?
Cancers Originate from Somatic Mutations in a Single Cell
Ovarian Cycle
Thomson's e/m Experiment
A particle with charge q, speed v, and mass m enters an area from the top, where the magnetic and electric fields are perpendicular both to the particle's motion and to one another. The magnetic...

